Interaction between serotonin transporter gene, catechol-O- methyltransferase gene and stressful life events in mood disorders

International Journal of Neuropsychopharmacology

Volumn 10, Issue 4, 2007, Pages 437-447

  Mandelli, Laura ^a   Serretti, Alessandro ^a   Marino, Elena ^b   Pirovano, Adele ^b   Calati, Raffaella ^a   Colombo, Cristina ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Dopamine; Gene environment; Genetics; Serotonin; Stress

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENOTYPE; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; RISK FACTOR; STRESS;

ADULT; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); QUESTIONNAIRES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, DOPAMINE D4; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 34250858272     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706006882     Document Type: Article

References (74)

1. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol H (1995). Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry 65, 1157-1165.
2. Auerbach JG, Faroy M, Ebstein R, Kahana M, Levine J (2001). The association of the dopamine D4 receptor gene (DRD4) and the serotonin transporter promoter gene (5-HTTLPR) with temperament in 12-month-old infants. Journal of Child Psychology and Psychiatry 42, 777-783.
3. Bau CH, Roman T, Almeida S, Hutz MH (1999). Dopamine D4 receptor gene and personality dimensions in Brazilian male alcoholics. Psychiatric Genetics 9, 139-143.
4. Benjamin J, Li L, Patterson C, Greenberg B, Murphy D, Hamer D (1996). Population and familial association between the D4 dopamine receptor and measures of Novelty Seeking. Nature Genetics 12, 81-84.
5. Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL (2005). Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 132, 151-166.
6. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854.
7. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
8. Cavalli-Sforza L (1994). The History and Geography of Human Genes. Princeton, New Jersey, USA: Princeton University Press.
9. Charney DS, Manji HK (2004). Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE Mar 16; (225): re5.
10. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates.
11. Deakin JFW (1998). The role of serotonin in depression and anxiety. European Psychiatry 13, S57-S63.
12. Ebstein RP, Levine J, Geller V, Auerbach J, Gritsenko I, Belmaker RH (1998). Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Molecular Psychiatry 3, 238-246.
13. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Kats M, Belmaker RH (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics 12, 78-80.
14. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW (2004). Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry 9, 908-915.
15. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, Riemann R, Spinath F, Craig I (2003). Association analysis of MAOA and COMT with neuroticism assessed by peers. American Journal of Medical Genetics (B Neuropsychiatric Genetics) 120, 90-96.
16. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003). Genetic origins of anxiety in women: a role for a functional catechol-O- methyltransferase polymorphism. Psychiatric Genetics 13, 33-41.
17. First MB, Spitzer RL, Gibbon M, Williams JB (1995). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
18. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC (1998). Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics 81, 58-63.
19. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, Govea N, Mila M, Della Monica M, Ventruto V, De Benedetto M, et al. (1997). Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. European Journal of Human Genetics 5, 83-88.
20. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics 88, 83-87.
21. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R, Fananas L (1997). Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. American Journal of Psychiatry 154, 113-115.
22. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry 62, 146-152.
23. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR (2002a). Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403.
24. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR (2002b). The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 17, 317-323.
25. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40-68; image 5.
26. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch P (1996). Allelic variation of human serotonin trasporter gene expression. Journal of Neurochemistry 66, 2621-2624.
27. Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, Gelernter J (2004). Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences USA 101, 17316-17321.
28. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC (1987). The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540-548.
29. Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ (1993). The prediction of major depression in women: toward an integrated etiologic model. American Journal of Psychiatry 150, 1139-1148.
30. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Archives of General Psychiatry 62, 529-535.
31. Kessler RC (1997). The effects of stressful life events on depression. Annual Review of Psychology 48, 191-214.
32. Khoury MJ, Flanders WD (1996). Nontraditional epidemiologic approaches in the analysis of geneenvironment interaction: case-control studies with no controls! American Journal of Epidemiology 144, 207-213.
33. Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA (1997). No evidence for an association of affective disorders with high- or low-activity allele of catechol-o- methyltransferase gene. Biological Psychiatry 42, 282-285.
34. Lahiri DK, Nurnberger JIJ (1991). A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 19, 5444.
35. Lakatos K, Nemoda Z, Birkas E, Ronai Z, Kovacs E, Ney K, Toth I, Sasvari-Szekely M, Gervai J (2003). Association of D4 dopamine receptor gene and serotonin transporter promoter polymorphisms with infants' response to novelty. Molecular Psychiatry 8, 90-97.
36. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT (2005). Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. American Journal of Medical Genetics (B Neuropsychiatric Genetics) 133, 110-115.
37. Lau KF, Miller CC, Anderton BH, Shaw PC (1999). Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics 60, 121-128.
38. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM (1982). Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry 39, 879-883.
39. Lemonde S, Turecki G, Bakish D, Du L, Hrdina P, Bown C, Sequeira A, Kushwaha N, Morris S, Basak A, et al. (2003). Impaired trans-repression at a 5-HT1A receptor gene polimorphism associated with major depression and suicide. Journal of Neuroscience 23, 8788-8799.
40. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
41. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ (1993). A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Human Molecular Genetics 2, 767-773.
42. Lotrich FE, Pollock BG (2004). Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatric Genetics 14, 121-129.
43. McGough JJ (2005). Attention-deficit/hyperactivity disorder pharmacogenomics. Biological Psychiatry 57, 1367-1373.
44. Nazroo JY, Edwards AC, Brown GW (1997). Gender differences in the onset of depression following a shared life event: a study of couples. Psychological Medicine 27, 9-19.
45. Oroszi G, Goldman D (2004). Alcoholism: genes and mechanisms. Pharmacogenomics 5, 1037-1048.
46. Paykel ES (1994). Life events, social support and depression. Acta Psychiatrica Scandinavica (Suppl.) 377, 50-58.
47. Paykel ES (2003). Life events and affective disorders. Acta Psychiatrica Scandinavica (Suppl.) 61-66.
48. Piegorsch WW, Weinberg CR, Taylor JA (1994). Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Statistics in Medicine 13, 153-162.
49. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences USA 95, 14476-14481.
50. Reuter M, Hennig J (2005). Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. Neuroreport 16, 1135-1138.
51. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ (2003). A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biological Psychiatry 54, 34-39.
52. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics 103, 273-279.
53. Schinka JA, Busch RM, Robichaux-Keene N (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 9, 197-202.
54. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. American Journal of Medical Genetics 127B, 90-93.
55. 1A gene promoter and antidepressant response in mood disorders: preliminary findings. International Journal of Neuropsychopharmacology 7, 453-460.
56. Serretti A, Cusin C, Benedetti F, Mandelli L, Pirovano A, Zanardi R, Colombo C, Smeraldi E (2005a). Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. American Journal of Medical Genetics (B Neuropsychiatric Genetics) 10, 10.
57. Serretti A, Cusin C, Cristina S, Lorenzi C, Lilli R, Lattuada E, Grieco G, Costa A, Santorelli F, Barale F, et al. (2003). Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatric Genetics 13, 121-126.
58. Serretti A, Lattuada E, Catalano M, Smeraldi E (1999). Serotonin transporter gene not associated with psychotic symptomatology of mood disorders. Psychiatry Research 86, 59-65.
59. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (2002a). Serotonin transporter gene (5-HTTLPR) and major psychoses. Molecular Psychiatry 7, 95-99.
60. Serretti A, Lorenzi C, Lilli R, Mandelli L, Pirovano A, Smeraldi E (2002b). Pharmacogenetics of lithium prophylaxis in mood disorders: Analysis of COMT, MAO-A, and Gbeta3 variants. American Journal of Medical Genetics 114, 370-379.
61. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Smeraldi E (1998). Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Research 80, 129-136.
62. Serretti A, Mandelli L, Lorenzi C, Landoni S, Calati R, Insacco C, Cloninger CR (2005b). Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Neuropsychobiology 53, 9-16.
63. Serretti A, Zanardi R, Cusin C, Rossini D, Lilli R, Lorenzi C, Lattuada E, Smeraldi E (2001). No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. Psychiatry Research 104, 195-203.
64. Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molecular Psychiatry 3, 508-511.
65. Spoont MR (1992). Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychological Bulletin 112, 330-350.
66. Stein MB, Fallin MD, Schork NJ, Gelernter J (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30, 2092-2102.
67. Tsai SJ, Hong CJ, Yu YW, Chen TJ (2004). Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young chinese females. Neuropsychobiology 50, 153-156.
68. Tsuchiya KJ, Byrne M, Mortensen PB (2003). Risk factors in relation to an emergence of bipolar disorder: a systematic review. Bipolar Disorders 5, 231-242.
69. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-1106.
70. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76.
71. Weinshilboum RM, Raymond FA (1977). Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. American Journal of Human Genetics 29, 125-135.
72. Wurtman RJ (2005). Genes, stress, and depression. Metabolism 54, 16-19.
73. Zanardi R, Benedetti F, DiBella D, Catalano M, Smeraldi E (2000). Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. Journal of Clinical Psychopharmacology 20, 105-107.
74. Zylka MJ, Shearman LP, Weaver DR, Reppert SM (1998). Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20, 1103-1110.